
Spectrum Pharmaceuticals SPPI
Spectrum Pharmaceuticals ROE | SPPI
ROE Jährlich Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -270.37 | -333.58 | -119.83 | -59.19 | -19.57 | -26.24 | -29.56 | -24.73 | -17.96 | -22.06 | 32.63 | 26.57 | -65.58 | -17.58 | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 32.63 | -333.58 | -67.65 |
ROE Vierteljährlich Spectrum Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -198.92 | -208.18 | -259.48 | -239.96 | -199.26 | -200.47 | -146.57 | -133.72 | -112.12 | -109.35 | -100.85 | -83.73 | -70.86 | -51.86 | -50.32 | -62.79 | -46.78 | -45.32 | -33.88 | -15.88 | -30.5 | -35.13 | -34.67 | -35.49 | -35.49 | -29.4 | -23.68 | -25.44 | -16.15 | -22.77 | -21.99 | -17.76 | -18.1 | -17.4 | -30.14 | -28.23 | -30.39 | -21.9 | -5.4 | 4.88 | 15.36 | 36.83 | 38.65 | 42.6 | 41.95 | 29.19 | 11.65 | 6.33 | 6.8 |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 42.6 | -259.48 | -53.39 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Kadmon Holdings, Inc.
KDMN
|
-93.87 | - | - | $ 1.7 B | ||
|
Liminal BioSciences
LMNL
|
1.72 | - | - | $ 256 M | ||
|
argenx SE
ARGX
|
17.64 | $ 926.42 | -1.66 % | $ 56.8 B | ||
|
Tonix Pharmaceuticals Holding Corp.
TNXP
|
-50.59 | $ 2.33 | -7.25 % | $ 19.8 M | ||
|
Zai Lab Limited
ZLAB
|
-24.53 | $ 21.01 | -4.16 % | $ 23 B | ||
|
Neos Therapeutics, Inc.
NEOS
|
275.73 | - | -2.54 % | $ 57.2 M | ||
|
Zentalis Pharmaceuticals
ZNTL
|
-63.39 | $ 1.37 | 0.74 % | $ 98.5 M | ||
|
Zoetis
ZTS
|
80.25 | $ 78.81 | -2.47 % | $ 34.9 B | ||
|
Odonate Therapeutics, Inc.
ODT
|
-92.81 | - | -3.18 % | $ 58.5 M | ||
|
Orphazyme A/S
ORPH
|
-102.05 | - | -2.25 % | $ 31.3 M | ||
|
Osmotica Pharmaceuticals plc
OSMT
|
-84.8 | - | -10.74 % | $ 89.9 M | ||
|
Pandion Therapeutics, Inc.
PAND
|
-17745.54 | - | - | $ 1.77 B | ||
|
Xenetic Biosciences
XBIO
|
-36.25 | $ 1.47 | -4.55 % | $ 2.5 M | ||
|
Translate Bio, Inc.
TBIO
|
-15.08 | - | - | $ 2.81 B | ||
|
Trillium Therapeutics Inc.
TRIL
|
-21.28 | - | - | $ 1.94 B | ||
|
Urovant Sciences Ltd.
UROV
|
252.98 | - | - | $ 532 M | ||
|
Acceleron Pharma Inc.
XLRN
|
-14.6 | - | - | $ 10.9 B | ||
|
Zogenix, Inc.
ZGNX
|
-56.64 | - | -4.97 % | $ 664 M | ||
|
Yunhong International
ZGYH
|
-1.19 | - | 0.10 % | $ 92.2 M | ||
|
ZIOPHARM Oncology, Inc.
ZIOP
|
-64.51 | - | -7.58 % | $ 264 M | ||
|
Taysha Gene Therapies
TSHA
|
-44.14 | $ 3.71 | -1.72 % | $ 1.19 B | ||
|
Vericel Corporation
VCEL
|
4.66 | $ 57.41 | -1.46 % | $ 2.89 B | ||
|
Vir Biotechnology
VIR
|
-57.23 | $ 8.37 | -5.64 % | $ 1.16 B | ||
|
Veracyte
VCYT
|
5.07 | $ 25.08 | 0.16 % | $ 1.97 B | ||
|
Viking Therapeutics
VKTX
|
-56.28 | $ 24.72 | -4.35 % | $ 2.79 B | ||
|
Vanda Pharmaceuticals
VNDA
|
-67.39 | $ 3.44 | -6.27 % | $ 203 M | ||
|
VistaGen Therapeutics
VTGN
|
-196.2 | $ 0.16 | -12.33 % | $ 6.09 M | ||
|
Voyager Therapeutics
VYGR
|
-61.06 | $ 1.52 | -5.9 % | $ 89.2 M | ||
|
Verrica Pharmaceuticals
VRCA
|
-72.34 | $ 2.74 | -5.03 % | $ 29.2 M | ||
|
Wave Life Sciences Ltd.
WVE
|
-39.43 | $ 2.56 | -6.07 % | $ 432 M | ||
|
XBiotech
XBIT
|
-32.45 | $ 1.75 | 4.17 % | $ 53.4 M | ||
|
XTL Biopharmaceuticals Ltd.
XTLB
|
-18.9 | $ 1.37 | -7.43 % | $ 922 M | ||
|
Adial Pharmaceuticals
ADIL
|
-151.18 | $ 3.15 | -35.42 % | $ 2.11 M | ||
|
ADMA Biologics
ADMA
|
30.78 | $ 13.18 | -1.2 % | $ 3.14 B | ||
|
Exicure
XCUR
|
-125.98 | $ 0.96 | -7.24 % | $ 6.05 M | ||
|
Xencor
XNCR
|
-14.46 | $ 33.48 | -1.56 % | $ 2.49 B | ||
|
Cortexyme
CRTX
|
235.14 | - | -1.05 % | $ 67.1 M | ||
|
Burford Capital Limited
BUR
|
2.56 | $ 3.24 | -5.55 % | $ 710 M | ||
|
Daré Bioscience
DARE
|
-471.39 | $ 0.41 | -9.93 % | $ 4.58 M | ||
|
Fate Therapeutics
FATE
|
-65.79 | $ 0.92 | -9.07 % | $ 109 M | ||
|
Greenwich LifeSciences
GLSI
|
-5480.55 | $ 19.09 | -3.54 % | $ 258 M | ||
|
Halozyme Therapeutics
HALO
|
649.18 | $ 91.28 | -1.89 % | $ 10.9 B | ||
|
Hutchison China MediTech Limited
HCM
|
36.91 | $ 13.18 | -2.04 % | $ 11.3 B | ||
|
Aptorum Group Limited
APM
|
-5.9 | - | - | $ 5.72 M | ||
|
iBio
IBIO
|
-38.31 | $ 0.83 | 3.01 % | $ 86.4 M | ||
|
Kodiak Sciences
KOD
|
-146.12 | $ 97.05 | -0.87 % | $ 5.16 B | ||
|
Karyopharm Therapeutics
KPTI
|
66.92 | $ 0.02 | -56.5 % | $ 219 | ||
|
FSD Pharma
HUGE
|
-528.29 | - | 5743.5 % | $ 69.7 M | ||
|
BioAtla
BCAB
|
-1.25 | $ 1.74 | 0.64 % | $ 102 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
22.46 | - | - | $ 3.85 B |